Kidney Transplantation
📧 Sign up to get email alerts when something new happens for Kidney Transplantation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Safety of Immunosuppression Minimization in Children and Adolescents After Kidney Transplantation [Phase 1]
This report updates findings from a Phase 1 trial evaluating safety of reducing immunosuppression in children and adolescents after kidney t…
-
CLINICAL_TRIALS trial_result · 2013-02-12Clinical Trial Update: Study of ISA247 (Voclosporin) in De Novo Renal Transplantation [Phase 2]
This clinical trial update reports the completion of a Phase 2 study evaluating ISA247 (voclosporin) in de novo renal transplantation, with …
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Optima: Optimizing Prograf Therapy in Maintenance Allografts II [Phase 4]
Phase 4 trial update on optimizing Prograf therapy in maintenance kidney transplant recipients; completed with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Antibody and Delayed Cyclosporine Versus Initial Cyclosporine Alone in Patients Receiving Kidney Transplants [NA]
Clinical trial comparing an unspecified antibody plus delayed cyclosporine versus initial cyclosporine alone in kidney transplant recipients…
-
CLINICAL_TRIALS trial_result · 2013-01-03Clinical Trial Update: The Study of Long-term Deterioration of Kidney Transplants.
A completed clinical trial update examining long-term deterioration in kidney transplant recipients.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-12-10FDA Approved: TACROLIMUS — Supplemental Application (Sandoz Inc.)
FDA approved a supplemental application for tacrolimus from Sandoz Inc., updating labeling related to its use in preventing organ transplant…
-
CLINICAL_TRIALS trial_result · 2012-12-06Clinical Trial Update: Early Conversion From Tacrolimus to Efalizumab Maintenance Therapy in Kidney Transplant Recipients [Phase 1, Phase 2]
This clinical trial update reports a Phase 1/2 study on converting kidney transplant patients from tacrolimus to efalizumab maintenance ther…
-
CLINICAL_TRIALS trial_result · 2012-10-25Clinical Trial Update: Safety in Immunomodulatory Functions of Alemtuzumab (Campath) in Pediatric Kidney Transplantation Recipients [Phase 2]
This Phase 2 trial update reports on the safety and immunomodulatory effects of alemtuzumab (Campath) in pediatric kidney transplant recipie…
-
CLINICAL_TRIALS trial_result · 2012-10-03Clinical Trial Update: The Biomarker for Immunosuppressive Agents Metabolism in Chinese Renal Transplant Recipients [Phase 4]
A Phase 4 clinical trial update from Central South University studying biomarkers of immunosuppressant metabolism in Chinese kidney transpla…
-
FDA approval · 2012-09-25FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approves a supplemental application for mycophenolate mofetil, the generic immunosuppressant, via Teva Pharmaceuticals USA, Inc. This ac…
-
CLINICAL_TRIALS trial_result · 2012-09-17Clinical Trial Update: Pharmacogenetic Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients. [Phase 4]
A Phase 4 pharmacogenetic study of CellCept (mycophenolate mofetil) in kidney transplant patients has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-03Clinical Trial Update: Study Evaluating of Calcineurin Inhibitors Versus Sirolimus in Renal Allograft Recipient [Phase 4]
This Phase 4 clinical trial comparing calcineurin inhibitors with sirolimus in renal allograft recipients was terminated; results were poste…
-
FDA approval · 2012-08-31FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for mycophenolate mofetil from Strides Pharma Science Limited. This approval supports continued …
-
FDA approval · 2012-08-29FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application to allow Strides Pharma Science Limited to market a generic version of mycophenolate mofetil.
-
CLINICAL_TRIALS trial_result · 2012-07-25Clinical Trial Update: Desensitization of Renal Transplant Candidates [Phase 1]
Phase 1 clinical trial evaluating desensitization for renal transplant candidates has completed. The study involved patients with End-Stage …
-
CLINICAL_TRIALS trial_result · 2012-07-09Clinical Trial Update: A Study of the Impact of an Early Biopsy in Patients Treated With CellCept (Mycophenolate Mofetil) After Kidney Transplantation [Phase 4]
This Phase 4 trial update evaluates the impact of an early biopsy in kidney transplant patients treated with mycophenolate mofetil (CellCept…
-
CLINICAL_TRIALS trial_result · 2012-06-26Clinical Trial Update: MMF Monotherapy and Immune Regulation in Kidney Transplant Recipients: Part 1 Steroid Withdrawal [NA]
A completed clinical trial evaluating mycophenolate mofetil monotherapy with steroid withdrawal in kidney transplant recipients.
-
CLINICAL_TRIALS trial_result · 2012-06-21Clinical Trial Update: Pharmacokinetics of Generic to Brand Tacrolimus in Stable Renal Transplant Patients [Phase 4]
Phase 4 pharmacokinetic study comparing generic tacrolimus to brand tacrolimus in stable kidney transplant recipients; results were posted i…
-
CLINICAL_TRIALS trial_result · 2012-06-19Clinical Trial Update: Effectiveness and Safety of Campath in Combination With Tacrolimus Monotherapy to Prevent Kidney Graft Rejection [Phase 3]
Phase 3 clinical trial evaluating the effectiveness and safety of alemtuzumab (Campath) in combination with tacrolimus monotherapy to preven…
-
FDA approval · 2012-06-08FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for CELLCEPT (mycophenolate mofetil) submitted by Genentech, Inc.
-
CLINICAL_TRIALS research · 2012-06-08Clinical Trial Update: Study of Subclinical Viral Infection
An update on a clinical trial studying subclinical viral infection sponsored by Seattle Children's Hospital, involving kidney transplantatio…
-
CLINICAL_TRIALS research · 2012-05-31Clinical Trial Update: A Clinical Trial to Assess the Efficacy and Safety of the Conversion to Everolimus [Phase 4]
Phase 4 clinical trial update evaluating the efficacy and safety of converting kidney transplant recipients to everolimus (Afinitor).
-
CLINICAL_TRIALS trial_result · 2012-04-19Clinical Trial Update: Mycophenolate Mofetil for Reducing Cardiovascular Risk in Renal Transplant Recipients [Phase 3]
Phase 3 trial evaluating mycophenolate mofetil to reduce cardiovascular risk in kidney transplant recipients has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-04-06Clinical Trial Update: Intraperative Assessment of Renal Perfusion Using Infrared Imaging
This update summarizes a completed clinical trial evaluating intraoperative infrared imaging for assessing renal perfusion during kidney tra…
-
CLINICAL_TRIALS withdrawal · 2012-02-22Clinical Trial Update: Alefacept in Kidney Transplant Recipients [NA]
The clinical trial evaluating alefacept in kidney transplant recipients has been withdrawn.